SlideShare a Scribd company logo
Presented By:
Jim Wachtel
National Sales Director
Jim.wachtel@healthcheck360.com




                                 1
Claims Experience Correlated to Health Score

                                     Paid Claims
   $12,000.00


                                                                                       $10,214.99
   $10,000.00



                                                              $7,826.56
    $8,000.00


                                 $6,391.89

    $6,000.00


                $4,229.58
    $4,000.00




    $2,000.00




          $-
                Ideal (85+)   Low Risk (71-84)          Moderate Risk (61-70)   High/ Very High Risk(<60)




  8/8/2012                      Proprietary & Confidential
                                                                                                            2
Score Increase in Repeat Participants

                  Program Efficacy - Score Increase for Repeat Participants Only
  82.00


                                                                                   81.04
  80.00



  78.00

                                                              77.43
  76.00
                                     75.70

  74.00
          74.00

  72.00



  70.00
          2008                       2009                     2010                 2011
Overall Health Score – Repeat Participants
                                                          ABC Company
                                            Participants who took HRA in 2010 AND 2011

                          General Statistics
                  2010         2011        Variance
 Population        491          491          N/A
                                                                    Average Score Increase/Decrease/No Change from Year 2 to Year 3
  Average          81.1         83.1          2.0                  2010 Range Increase     Decrease No Change      Total
   St Dev          12.3         12.2          0.1                      96+         2.2       (4.8)       NA        (1.7)
                                                                      95-90        3.9       (5.1)       NA        (0.3)
              Overall Score Distribution                              89-80        6.2       (6.6)       NA         1.8
    96+            54            84            30                     79-70        8.4       (6.8)       NA         3.0
   95-90           91            99             8                     69-60        9.8       (4.3)       NA         4.8
   89-80          148           138           (10)                    59-50       11.5       (5.4)       NA         7.5
   79-70          106            95           (11)                     <50        11.7       (3.0)       NA         8.0
   69-60           61            57            (4)                 Grand Total     7.0       (5.7)       NA         2.0
   59-50           27            14           (13)
    <50             4             4             0
   Total          491           491             0

                                         Increase/Decrease/No Change from Year 1 to Year 2

 2010 Range     Increase      Decrease     No Change    Total      2010 Range   Increase     Decrease No Change     Total
     96+            18           27             9         54           96+        33.3%       50.0%     16.7%      100.0%
    95-90           42           38            11         91          95-90       46.2%       41.8%     12.1%      100.0%
    89-80           93           48             7        148          89-80       62.8%       32.4%      4.7%      100.0%
    79-70           64           32            10        106          79-70       60.4%       30.2%      9.4%      100.0%
    69-60           37           16             8         61          69-60       60.7%       26.2%     13.1%      100.0%
    59-50           20            5             2         27          59-50       74.1%       18.5%      7.4%      100.0%
     <50             3            1             0          4           <50        75.0%       25.0%      0.0%      100.0%
 Grand Total       277          167            47        491          Total       56.4%       34.0%      9.6%      100.0%



 8/8/2012                                                Proprietary & Confidential
                                                                                                                                      4
Case Study – Partial Union Environment

                                          Plan Costs/Premiums per Covered
                              Plan Year
                                                      Employee
                              2007-2008                $8,852
                              2008-2009               $9,054
                              2009-2010               $8,365
                              2010-2011               $8,967
                              2011-2012               $8,823




     • Medical and drug costs have actually decreased on a per employee and per
     member basis over the last five years.
     • If medical plan costs had increased at rate of 8% per year since 2007-08, ABC
     Company premiums would be $7.24 million dollars higher than today. Total
     Wellness investment less than $1m in same period.



 Proprietary & Confidential                                                            5
Case Study – Partial Union Environment
                         Typical Profile of New v. Repeat Participant
                                            Avg.    Avg.     Avg.        Avg.     Avg. Total  Avg.   Nicotine
  Biometric Profile            2011 Score
                                            BMI    Weight   Systolic   Diastolic Cholesterol Glucose   POS
 Repeat Participants              76.6      29.0   192.8     120.4       76.3      192.6      97.8     26%

First Time Participants           67.9      29.9   203.2     124.4       78.3      195.7     101.7     22%

  Of the 612 repeat participants between 2010 and 2011, the overall average health score
   increased from 72.6 to 76.6. There was an improvement in health score in almost every
   risk category (with the exception of those scoring over 96).
  Overall blood pressure for these same participants decreased, as did the overall cholesterol
   levels.
  Of the 40 people who were at extremely high risk for blood pressure in 2010, 30 moved to
   be at moderate, low, or ideal categories.
  Of the 173 people with high or very high cholesterol risk, nearly 45% moved to moderate,
   low, or ideal categories.
  The number of people with very high glucose levels fell 35%.


  Proprietary & Confidential                                                                             6
Repeat Participation = Reduced Claims Expense



                                              $5,493.29
           3 HRA w/ biometrics




                                                      $5,838.68
           2 HRA w/ biometrics




                                                                  $6,202.27
           1 HRA w/ biometrics




                                                                                                                  $8,132.47
     Non-participant/ HRA Only




                           $5,000.00   $5,500.00   $6,000.00   $6,500.00      $7,000.00   $7,500.00   $8,000.00    $8,500.00


Large Financial Services Firm

   Proprietary & Confidential                                                                                                  7
Medical Trend Claims Analysis


  $11,500.00
                                                                     2007: Client’s trends
                                                                      increase exponentially
  $11,000.00
                   HealthCheck360°
  $10,500.00
                   implemented in
                   2008.
                                                                     2008: HC360° Implemented
  $10,000.00
                                                                     2010 actual claims
   $9,500.00
                                                                      demonstrated:
   $9,000.00
                                                                       – Trend reduced to low single
   $8,500.00
                                                                         digits for two straight years
   $8,000.00
                                                                       – $959,051 saving from
   $7,500.00                                                             expected trend
   $7,000.00
                 2006       2007      2008      2009         2010
                                                                       – $1,470,386 savings from
          Cost per employee on plan   Average for Industry
                                                                         industry average trend
          Expected Claims




 Proprietary & Confidential                                                                              8
Correlation to Health Score in Population

                                                  Score Correlation
                               $12,000.00
 Average claims per HRA
   participant:                $10,000.00


                                $8,000.00
  Year 1 – $7,057.57
                                $6,000.00

  Year 2 – $6,023.68           $4,000.00


                                $2,000.00


                                      $-
                                            85+        71-84      61-70       51-60   50 or less

                                                  Linear (2009)     Linear (2010)




 N = 1589


  Proprietary & Confidential                                                                       9
Biometrics and Medical Expense

          Glucose Level Correlation to Avg.                                                              BMI Level Correlation to Avg.
             Claims (medical claims only)                                                                 Claims (medical claims only)
$4,500                                                                                              $7,000
                                                                 $4,253
                                                                                                    $6,000
$4,000




                                                                          Incurred Medical Claims
                                                                                                    $5,000

$3,500
                                                                                                    $4,000

                                         $2,973
$3,000                                                                                              $3,000

                                                                                                    $2,000
$2,500            $2,316
                                                                                                    $1,000

$2,000
                                                                                                       $0
                Ideal < 100         Moderate 100-125        High 126+                                        < 18   18-25   25-29         30-34   35-39   40+

                      Avg. Claims         Linear (Avg. Claims)                                                                      BMI




Actual Results from HC360° Client Pool


    Proprietary & Confidential                                                                                                                            10
Impact of Nicotine Use on Claims

                              Nicotine Use Correlation to Avg. Claims
                                       (medical claims only)
   $8,000

   $7,000

   $6,000

   $5,000

   $4,000

   $3,000

   $2,000

   $1,000

       $0
                   18-29           30-39            40-49        50-59   60+

                                              NEG       POS




 N = 18,000


 Proprietary & Confidential                                                    11
Impact of Health on WC Costs




                                                     Total
                                 Total Score   Counts    Avg WC
                                    <50            150     $875.76
                                   50-59           206 $1,007.89
                                   60-75           561     $771.36
                                   76-85           342     $703.24
                                    86+            330     $366.25
                                    Total        1,589     $713.09

N = 1,589


    Proprietary & Confidential                                       12
Doing Nothing is a Losing Strategy
                Migration study of 43,312 Individuals Over 3 Years
            Year 0                                        Year 3
                                                                        Key Findings
        Low Risk (0-2                                  Low Risk (0-2     Risk profile of a population
        Health Risks)                                  Health Risks)      gets worse over time
           27,951                                         26,591
                                                                         Number of high risk
                                                                          individuals increased
                                                                          11.4%
       Medium Risk (3-                                Medium Risk (3-
       4 Health Risks)                                4 Health Risks)    Number of medium risk
           10,670                                         11,495          individuals increased 7.7%
                                                                         Number of low risk
                                                                          individuals decreased 4.9%
                                                        High Risk (5+    Results are a function of
         High Risk (5+
         Health Risks)                                  Health Risks)     American lifestyle habits
            4,691                                          5,226          and the realities of age

 Source: University of Michigan Health Management Research Center



 Proprietary & Confidential                                                                    13
Excess Risk Equals Excess Cost

    Cost Area                        Low Risk             Medium         High Risk
                                     (N=671)                Risk         (N=396)
                                                          (N=504)
    Short-Term                          $160                 $288          $444       High Risk
    Disability                                                                       Employees
    Worker’s                            $304                 $325          $662       cost three
    Compensation                                                                       times as
    Absence                             $327                 $455          $703      much as low
                                                                                         risk
    Medical &                          $1,544               $1,983        $4,929     employees!
    Pharmacy
    Total                              $2,335               $3,052        $6,738

    Source: University of Michigan Health Management Research Center
    Inflation adjusted to 2009: http://www.halfhill.com/inflation.html



 Proprietary & Confidential                                                                   14
Presented By:
Jim Wachtel
National Sales Director
Jim.wachtel@healthcheck360.com
(563) 289-7360

More Related Content

What's hot

Michigan Energy Forum - June 7, 2012 - Knut Simonsen
Michigan Energy Forum - June 7, 2012 - Knut SimonsenMichigan Energy Forum - June 7, 2012 - Knut Simonsen
Michigan Energy Forum - June 7, 2012 - Knut Simonsen
AnnArborSPARK
 
merck 2Q08 Other Financial Disclosures
merck  	2Q08 Other Financial Disclosuresmerck  	2Q08 Other Financial Disclosures
merck 2Q08 Other Financial Disclosuresfinance11
 
merck 4Q08 Other Financial Disclosures
merck  	4Q08 Other Financial Disclosuresmerck  	4Q08 Other Financial Disclosures
merck 4Q08 Other Financial Disclosuresfinance11
 
BBB2005Annual
BBB2005AnnualBBB2005Annual
BBB2005Annualfinance44
 
Main World Equity Indices Fundamental Value - Based on Analyst Estimates
Main World Equity Indices Fundamental Value - Based  on Analyst EstimatesMain World Equity Indices Fundamental Value - Based  on Analyst Estimates
Main World Equity Indices Fundamental Value - Based on Analyst Estimates
BCV
 
MHA How Safe Are Our Campuses??
MHA How Safe Are Our Campuses??MHA How Safe Are Our Campuses??
MHA How Safe Are Our Campuses??
Margolis Healy
 
NCRS10 - What is the link between distress and dysfunction (Sept10)
NCRS10 - What is the link between distress and dysfunction (Sept10)NCRS10 - What is the link between distress and dysfunction (Sept10)
NCRS10 - What is the link between distress and dysfunction (Sept10)
Alex J Mitchell
 
Good News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of MouthGood News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of MouthBSI
 
Update Status of the Enduring Drug Eluting Stents
Update Status of the Enduring Drug Eluting StentsUpdate Status of the Enduring Drug Eluting Stents
Update Status of the Enduring Drug Eluting Stents
Sociedad Latinoamericana de Cardiología Intervencionista
 
Sample house slides revised
Sample house slides revisedSample house slides revised
Sample house slides revisedMelissa Sions
 
Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11
Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11
Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11
HealthInnoventions
 
Community Market Report | August 2012
Community Market Report | August 2012Community Market Report | August 2012
Community Market Report | August 2012
Charter One Realty
 
Pat Services Case Study
Pat Services Case StudyPat Services Case Study
Pat Services Case Studyclandtime
 
Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012
Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012
Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012Deutsche EuroShop AG
 

What's hot (18)

Michigan Energy Forum - June 7, 2012 - Knut Simonsen
Michigan Energy Forum - June 7, 2012 - Knut SimonsenMichigan Energy Forum - June 7, 2012 - Knut Simonsen
Michigan Energy Forum - June 7, 2012 - Knut Simonsen
 
2012 Orange County Development Briefing
2012 Orange County Development Briefing2012 Orange County Development Briefing
2012 Orange County Development Briefing
 
Binder1
Binder1Binder1
Binder1
 
merck 2Q08 Other Financial Disclosures
merck  	2Q08 Other Financial Disclosuresmerck  	2Q08 Other Financial Disclosures
merck 2Q08 Other Financial Disclosures
 
merck 4Q08 Other Financial Disclosures
merck  	4Q08 Other Financial Disclosuresmerck  	4Q08 Other Financial Disclosures
merck 4Q08 Other Financial Disclosures
 
Equity research final
Equity research finalEquity research final
Equity research final
 
Afm group no 6
Afm group no 6Afm group no 6
Afm group no 6
 
BBB2005Annual
BBB2005AnnualBBB2005Annual
BBB2005Annual
 
Main World Equity Indices Fundamental Value - Based on Analyst Estimates
Main World Equity Indices Fundamental Value - Based  on Analyst EstimatesMain World Equity Indices Fundamental Value - Based  on Analyst Estimates
Main World Equity Indices Fundamental Value - Based on Analyst Estimates
 
MHA How Safe Are Our Campuses??
MHA How Safe Are Our Campuses??MHA How Safe Are Our Campuses??
MHA How Safe Are Our Campuses??
 
NCRS10 - What is the link between distress and dysfunction (Sept10)
NCRS10 - What is the link between distress and dysfunction (Sept10)NCRS10 - What is the link between distress and dysfunction (Sept10)
NCRS10 - What is the link between distress and dysfunction (Sept10)
 
Good News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of MouthGood News about Bad News – New Findings on Word of Mouth
Good News about Bad News – New Findings on Word of Mouth
 
Update Status of the Enduring Drug Eluting Stents
Update Status of the Enduring Drug Eluting StentsUpdate Status of the Enduring Drug Eluting Stents
Update Status of the Enduring Drug Eluting Stents
 
Sample house slides revised
Sample house slides revisedSample house slides revised
Sample house slides revised
 
Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11
Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11
Dodi Kelleher (Safeway) at Consumer Centric Health, Models for Change '11
 
Community Market Report | August 2012
Community Market Report | August 2012Community Market Report | August 2012
Community Market Report | August 2012
 
Pat Services Case Study
Pat Services Case StudyPat Services Case Study
Pat Services Case Study
 
Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012
Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012
Deutsche EuroShop - Conference Call Presentation - Interim Report H1 2012
 

Viewers also liked

HealthCheck360 Outcome Focused, Performance Based Wellness Presentation
HealthCheck360 Outcome Focused, Performance Based Wellness PresentationHealthCheck360 Outcome Focused, Performance Based Wellness Presentation
HealthCheck360 Outcome Focused, Performance Based Wellness Presentation
jim_wachtel
 
HC360 incentive strategies to improve health and reduce cost 051712
HC360 incentive strategies to improve health and reduce cost 051712HC360 incentive strategies to improve health and reduce cost 051712
HC360 incentive strategies to improve health and reduce cost 051712
jim_wachtel
 
Mobile-First SEO - The Marketers Edition #3XEDigital
Mobile-First SEO - The Marketers Edition #3XEDigitalMobile-First SEO - The Marketers Edition #3XEDigital
Mobile-First SEO - The Marketers Edition #3XEDigital
Aleyda Solís
 
SlideShare 101
SlideShare 101SlideShare 101
SlideShare 101
Amit Ranjan
 
A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...
A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...
A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...SlideShare
 
2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShare2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShare
SlideShare
 
What to Upload to SlideShare
What to Upload to SlideShareWhat to Upload to SlideShare
What to Upload to SlideShare
SlideShare
 
How to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & TricksHow to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & Tricks
SlideShare
 
Getting Started With SlideShare
Getting Started With SlideShareGetting Started With SlideShare
Getting Started With SlideShare
SlideShare
 

Viewers also liked (9)

HealthCheck360 Outcome Focused, Performance Based Wellness Presentation
HealthCheck360 Outcome Focused, Performance Based Wellness PresentationHealthCheck360 Outcome Focused, Performance Based Wellness Presentation
HealthCheck360 Outcome Focused, Performance Based Wellness Presentation
 
HC360 incentive strategies to improve health and reduce cost 051712
HC360 incentive strategies to improve health and reduce cost 051712HC360 incentive strategies to improve health and reduce cost 051712
HC360 incentive strategies to improve health and reduce cost 051712
 
Mobile-First SEO - The Marketers Edition #3XEDigital
Mobile-First SEO - The Marketers Edition #3XEDigitalMobile-First SEO - The Marketers Edition #3XEDigital
Mobile-First SEO - The Marketers Edition #3XEDigital
 
SlideShare 101
SlideShare 101SlideShare 101
SlideShare 101
 
A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...
A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...
A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...
 
2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShare2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShare
 
What to Upload to SlideShare
What to Upload to SlideShareWhat to Upload to SlideShare
What to Upload to SlideShare
 
How to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & TricksHow to Make Awesome SlideShares: Tips & Tricks
How to Make Awesome SlideShares: Tips & Tricks
 
Getting Started With SlideShare
Getting Started With SlideShareGetting Started With SlideShare
Getting Started With SlideShare
 

Similar to HealthCheck360 Wellness ROI Examples

Binary RS and Dynamic Asset Allocation
Binary RS and Dynamic Asset Allocation Binary RS and Dynamic Asset Allocation
Binary RS and Dynamic Asset Allocation Ann Treacy
 
AnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJAnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJ
Jornal do Commercio
 
Anefac - evolução mensal da taxa de juros PF
Anefac  - evolução mensal da taxa de juros PFAnefac  - evolução mensal da taxa de juros PF
Anefac - evolução mensal da taxa de juros PF
Jornal do Commercio
 
Recticel Annual Results 2011 - ENGLISH
Recticel Annual Results 2011 - ENGLISHRecticel Annual Results 2011 - ENGLISH
Recticel Annual Results 2011 - ENGLISH
Recticel NV/SA
 
MSU IIT MPC Ato Kini!
MSU IIT MPC
Ato Kini!MSU IIT MPC
Ato Kini!
MSU IIT MPC Ato Kini!VisualBee.com
 
CDHC 2. 0 October 2011
CDHC 2. 0 October 2011CDHC 2. 0 October 2011
CDHC 2. 0 October 2011
dcowles
 
CDHC 2 0 October 2011
CDHC  2 0 October 2011CDHC  2 0 October 2011
CDHC 2 0 October 2011dcowles
 
CDHC 2 0 October 2011
CDHC 2 0 October 2011CDHC 2 0 October 2011
CDHC 2 0 October 2011Benemax
 
Sightlines 2015 State of Facilities: An In-Depth Look at Capital Trends
Sightlines 2015 State of Facilities: An In-Depth Look at Capital TrendsSightlines 2015 State of Facilities: An In-Depth Look at Capital Trends
Sightlines 2015 State of Facilities: An In-Depth Look at Capital Trends
Sightlines
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
HMO Research Network
 
Banco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell
 
Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...
Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...
Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...
Sightlines
 
Profarma 4 q12
Profarma 4 q12Profarma 4 q12
Profarma 4 q12Profarma
 
2011 CMA Compensation Survey
2011 CMA Compensation Survey2011 CMA Compensation Survey
2011 CMA Compensation Survey
Council of Manufacturing Associations
 
BKW Budget Presentation 2012-13
BKW Budget Presentation 2012-13BKW Budget Presentation 2012-13
BKW Budget Presentation 2012-13bkwschools
 
What is the future of instore brand performance consumer behaviour
What is the future of instore brand performance  consumer behaviourWhat is the future of instore brand performance  consumer behaviour
What is the future of instore brand performance consumer behaviourLindaSidia
 
GEHB: Paying More for Less
GEHB: Paying More for LessGEHB: Paying More for Less
GEHB: Paying More for Less
lyndseyoday
 
Ratio Analysis on Maruti Suzuki
Ratio Analysis on Maruti SuzukiRatio Analysis on Maruti Suzuki
Ratio Analysis on Maruti Suzuki
Rahul's Ventures
 

Similar to HealthCheck360 Wellness ROI Examples (20)

Binary RS and Dynamic Asset Allocation
Binary RS and Dynamic Asset Allocation Binary RS and Dynamic Asset Allocation
Binary RS and Dynamic Asset Allocation
 
AnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJAnAefac - evolução mensal da taxa de juros PJ
AnAefac - evolução mensal da taxa de juros PJ
 
Anefac - evolução mensal da taxa de juros PF
Anefac  - evolução mensal da taxa de juros PFAnefac  - evolução mensal da taxa de juros PF
Anefac - evolução mensal da taxa de juros PF
 
Recticel Annual Results 2011 - ENGLISH
Recticel Annual Results 2011 - ENGLISHRecticel Annual Results 2011 - ENGLISH
Recticel Annual Results 2011 - ENGLISH
 
MSU IIT MPC Ato Kini!
MSU IIT MPC
Ato Kini!MSU IIT MPC
Ato Kini!
MSU IIT MPC Ato Kini!
 
CDHC 2. 0 October 2011
CDHC 2. 0 October 2011CDHC 2. 0 October 2011
CDHC 2. 0 October 2011
 
CDHC 2 0 October 2011
CDHC  2 0 October 2011CDHC  2 0 October 2011
CDHC 2 0 October 2011
 
CDHC 2 0 October 2011
CDHC 2 0 October 2011CDHC 2 0 October 2011
CDHC 2 0 October 2011
 
Sightlines 2015 State of Facilities: An In-Depth Look at Capital Trends
Sightlines 2015 State of Facilities: An In-Depth Look at Capital TrendsSightlines 2015 State of Facilities: An In-Depth Look at Capital Trends
Sightlines 2015 State of Facilities: An In-Depth Look at Capital Trends
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
 
Banco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell FY10 Results
Banco Sabadell FY10 Results
 
Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...
Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...
Exploring the State of Facilities 2014 [Part 4]: Operations Effectiveness & E...
 
Profarma 4 q12
Profarma 4 q12Profarma 4 q12
Profarma 4 q12
 
2011 CMA Compensation Survey
2011 CMA Compensation Survey2011 CMA Compensation Survey
2011 CMA Compensation Survey
 
BKW Budget Presentation 2012-13
BKW Budget Presentation 2012-13BKW Budget Presentation 2012-13
BKW Budget Presentation 2012-13
 
What is the future of instore brand performance consumer behaviour
What is the future of instore brand performance  consumer behaviourWhat is the future of instore brand performance  consumer behaviour
What is the future of instore brand performance consumer behaviour
 
GEHB: Paying More for Less
GEHB: Paying More for LessGEHB: Paying More for Less
GEHB: Paying More for Less
 
4Q12 Presentation
4Q12 Presentation4Q12 Presentation
4Q12 Presentation
 
Slide 1
Slide 1Slide 1
Slide 1
 
Ratio Analysis on Maruti Suzuki
Ratio Analysis on Maruti SuzukiRatio Analysis on Maruti Suzuki
Ratio Analysis on Maruti Suzuki
 

Recently uploaded

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 

HealthCheck360 Wellness ROI Examples

  • 1. Presented By: Jim Wachtel National Sales Director Jim.wachtel@healthcheck360.com 1
  • 2. Claims Experience Correlated to Health Score Paid Claims $12,000.00 $10,214.99 $10,000.00 $7,826.56 $8,000.00 $6,391.89 $6,000.00 $4,229.58 $4,000.00 $2,000.00 $- Ideal (85+) Low Risk (71-84) Moderate Risk (61-70) High/ Very High Risk(<60) 8/8/2012 Proprietary & Confidential 2
  • 3. Score Increase in Repeat Participants Program Efficacy - Score Increase for Repeat Participants Only 82.00 81.04 80.00 78.00 77.43 76.00 75.70 74.00 74.00 72.00 70.00 2008 2009 2010 2011
  • 4. Overall Health Score – Repeat Participants ABC Company Participants who took HRA in 2010 AND 2011 General Statistics 2010 2011 Variance Population 491 491 N/A Average Score Increase/Decrease/No Change from Year 2 to Year 3 Average 81.1 83.1 2.0 2010 Range Increase Decrease No Change Total St Dev 12.3 12.2 0.1 96+ 2.2 (4.8) NA (1.7) 95-90 3.9 (5.1) NA (0.3) Overall Score Distribution 89-80 6.2 (6.6) NA 1.8 96+ 54 84 30 79-70 8.4 (6.8) NA 3.0 95-90 91 99 8 69-60 9.8 (4.3) NA 4.8 89-80 148 138 (10) 59-50 11.5 (5.4) NA 7.5 79-70 106 95 (11) <50 11.7 (3.0) NA 8.0 69-60 61 57 (4) Grand Total 7.0 (5.7) NA 2.0 59-50 27 14 (13) <50 4 4 0 Total 491 491 0 Increase/Decrease/No Change from Year 1 to Year 2 2010 Range Increase Decrease No Change Total 2010 Range Increase Decrease No Change Total 96+ 18 27 9 54 96+ 33.3% 50.0% 16.7% 100.0% 95-90 42 38 11 91 95-90 46.2% 41.8% 12.1% 100.0% 89-80 93 48 7 148 89-80 62.8% 32.4% 4.7% 100.0% 79-70 64 32 10 106 79-70 60.4% 30.2% 9.4% 100.0% 69-60 37 16 8 61 69-60 60.7% 26.2% 13.1% 100.0% 59-50 20 5 2 27 59-50 74.1% 18.5% 7.4% 100.0% <50 3 1 0 4 <50 75.0% 25.0% 0.0% 100.0% Grand Total 277 167 47 491 Total 56.4% 34.0% 9.6% 100.0% 8/8/2012 Proprietary & Confidential 4
  • 5. Case Study – Partial Union Environment Plan Costs/Premiums per Covered Plan Year Employee 2007-2008 $8,852 2008-2009 $9,054 2009-2010 $8,365 2010-2011 $8,967 2011-2012 $8,823 • Medical and drug costs have actually decreased on a per employee and per member basis over the last five years. • If medical plan costs had increased at rate of 8% per year since 2007-08, ABC Company premiums would be $7.24 million dollars higher than today. Total Wellness investment less than $1m in same period. Proprietary & Confidential 5
  • 6. Case Study – Partial Union Environment Typical Profile of New v. Repeat Participant Avg. Avg. Avg. Avg. Avg. Total Avg. Nicotine Biometric Profile 2011 Score BMI Weight Systolic Diastolic Cholesterol Glucose POS Repeat Participants 76.6 29.0 192.8 120.4 76.3 192.6 97.8 26% First Time Participants 67.9 29.9 203.2 124.4 78.3 195.7 101.7 22%  Of the 612 repeat participants between 2010 and 2011, the overall average health score increased from 72.6 to 76.6. There was an improvement in health score in almost every risk category (with the exception of those scoring over 96).  Overall blood pressure for these same participants decreased, as did the overall cholesterol levels.  Of the 40 people who were at extremely high risk for blood pressure in 2010, 30 moved to be at moderate, low, or ideal categories.  Of the 173 people with high or very high cholesterol risk, nearly 45% moved to moderate, low, or ideal categories.  The number of people with very high glucose levels fell 35%. Proprietary & Confidential 6
  • 7. Repeat Participation = Reduced Claims Expense $5,493.29 3 HRA w/ biometrics $5,838.68 2 HRA w/ biometrics $6,202.27 1 HRA w/ biometrics $8,132.47 Non-participant/ HRA Only $5,000.00 $5,500.00 $6,000.00 $6,500.00 $7,000.00 $7,500.00 $8,000.00 $8,500.00 Large Financial Services Firm Proprietary & Confidential 7
  • 8. Medical Trend Claims Analysis $11,500.00  2007: Client’s trends increase exponentially $11,000.00 HealthCheck360° $10,500.00 implemented in 2008.  2008: HC360° Implemented $10,000.00  2010 actual claims $9,500.00 demonstrated: $9,000.00 – Trend reduced to low single $8,500.00 digits for two straight years $8,000.00 – $959,051 saving from $7,500.00 expected trend $7,000.00 2006 2007 2008 2009 2010 – $1,470,386 savings from Cost per employee on plan Average for Industry industry average trend Expected Claims Proprietary & Confidential 8
  • 9. Correlation to Health Score in Population Score Correlation $12,000.00 Average claims per HRA participant: $10,000.00 $8,000.00  Year 1 – $7,057.57 $6,000.00  Year 2 – $6,023.68 $4,000.00 $2,000.00 $- 85+ 71-84 61-70 51-60 50 or less Linear (2009) Linear (2010) N = 1589 Proprietary & Confidential 9
  • 10. Biometrics and Medical Expense Glucose Level Correlation to Avg. BMI Level Correlation to Avg. Claims (medical claims only) Claims (medical claims only) $4,500 $7,000 $4,253 $6,000 $4,000 Incurred Medical Claims $5,000 $3,500 $4,000 $2,973 $3,000 $3,000 $2,000 $2,500 $2,316 $1,000 $2,000 $0 Ideal < 100 Moderate 100-125 High 126+ < 18 18-25 25-29 30-34 35-39 40+ Avg. Claims Linear (Avg. Claims) BMI Actual Results from HC360° Client Pool Proprietary & Confidential 10
  • 11. Impact of Nicotine Use on Claims Nicotine Use Correlation to Avg. Claims (medical claims only) $8,000 $7,000 $6,000 $5,000 $4,000 $3,000 $2,000 $1,000 $0 18-29 30-39 40-49 50-59 60+ NEG POS N = 18,000 Proprietary & Confidential 11
  • 12. Impact of Health on WC Costs Total Total Score Counts Avg WC <50 150 $875.76 50-59 206 $1,007.89 60-75 561 $771.36 76-85 342 $703.24 86+ 330 $366.25 Total 1,589 $713.09 N = 1,589 Proprietary & Confidential 12
  • 13. Doing Nothing is a Losing Strategy Migration study of 43,312 Individuals Over 3 Years Year 0 Year 3 Key Findings Low Risk (0-2 Low Risk (0-2  Risk profile of a population Health Risks) Health Risks) gets worse over time 27,951 26,591  Number of high risk individuals increased 11.4% Medium Risk (3- Medium Risk (3- 4 Health Risks) 4 Health Risks)  Number of medium risk 10,670 11,495 individuals increased 7.7%  Number of low risk individuals decreased 4.9% High Risk (5+  Results are a function of High Risk (5+ Health Risks) Health Risks) American lifestyle habits 4,691 5,226 and the realities of age Source: University of Michigan Health Management Research Center Proprietary & Confidential 13
  • 14. Excess Risk Equals Excess Cost Cost Area Low Risk Medium High Risk (N=671) Risk (N=396) (N=504) Short-Term $160 $288 $444 High Risk Disability Employees Worker’s $304 $325 $662 cost three Compensation times as Absence $327 $455 $703 much as low risk Medical & $1,544 $1,983 $4,929 employees! Pharmacy Total $2,335 $3,052 $6,738 Source: University of Michigan Health Management Research Center Inflation adjusted to 2009: http://www.halfhill.com/inflation.html Proprietary & Confidential 14
  • 15. Presented By: Jim Wachtel National Sales Director Jim.wachtel@healthcheck360.com (563) 289-7360

Editor's Notes

  1. Implemented:HRA, Biometric screenings, outcome based incentives, and comprehensive health coaching in 2008
  2. Far too much emphasis on smoking alone and instead use a HC360 approach for holistic healthIn the long run smoking can have devastating impactBig spending after retirementThis is just claims costs, think about all the lost productivity (thinking of next cigarette, more breaks)
  3. Looking from start to year three, people trend the wrong direction